147 related articles for article (PubMed ID: 8898462)
1. Praziquantel side effects during treatment of Schistosoma mansoni infected pupils in Kibwezi, Kenya.
Jaoko WG; Muchemi G; Oguya FO
East Afr Med J; 1996 Aug; 73(8):499-501. PubMed ID: 8898462
[TBL] [Abstract][Full Text] [Related]
2. Praziquantel side effects and efficacy related to Schistosoma mansoni egg loads and morbidity in primary school children in north-east Ethiopia.
Berhe N; Gundersen SG; Abebe F; Birrie H; Medhin G; Gemetchu T
Acta Trop; 1999 Jan; 72(1):53-63. PubMed ID: 9924961
[TBL] [Abstract][Full Text] [Related]
3. Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates.
Fallon PG; Mubarak JS; Fookes RE; Niang M; Butterworth AE; Sturrock RF; Doenhoff MJ
Exp Parasitol; 1997 May; 86(1):29-36. PubMed ID: 9149238
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and side effects of praziquantel in the treatment of Schistosomiasis mansoni in schoolchildren in Shesha Kekele Elementary School, Wondo Genet, Southern Ethiopia.
Erko B; Degarege A; Tadesse K; Mathiwos A; Legesse M
Asian Pac J Trop Biomed; 2012 Mar; 2(3):235-9. PubMed ID: 23569905
[TBL] [Abstract][Full Text] [Related]
5. [Schistosomiasis mansoni infection in a hyperendemic region of midwestern Madagascar: epidemiology, morbidity and secondary effects of praziquantel treatment].
Boisier P; Ravaoalimalala VA; Serieye J; Roux J; Esterre P
Arch Inst Pasteur Madagascar; 1994; 61(1):43-8. PubMed ID: 7778950
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial.
Ferrari ML; Coelho PM; Antunes CM; Tavares CA; da Cunha AS
Bull World Health Organ; 2003; 81(3):190-6. PubMed ID: 12764515
[TBL] [Abstract][Full Text] [Related]
7. [Sensitivity of S. intercalatum to praziquantel (author's transl)].
Deniau M; Eben Moussi E; Same Ekobo A; Ripert C
Med Trop (Mars); 1981; 41(6):657-9. PubMed ID: 7339424
[TBL] [Abstract][Full Text] [Related]
8. Studies on the chemotherapy of human opisthorchiasis: effective dose of praziquantel in heavy infection.
Pungpak S; Bunnag D; Harinasuta T
Southeast Asian J Trop Med Public Health; 1985 Jun; 16(2):248-52. PubMed ID: 3906918
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and side effects of praziquantel in the treatment for Schistosoma mansoni infection in school children in Senbete Town, northeastern Ethiopia.
Reta B; Erko B
Trop Med Int Health; 2013 Nov; 18(11):1338-43. PubMed ID: 24103059
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of myrrh in the treatment of human Schistosomiasis mansoni.
Barakat R; Elmorshedy H; Fenwick A
Am J Trop Med Hyg; 2005 Aug; 73(2):365-7. PubMed ID: 16103605
[TBL] [Abstract][Full Text] [Related]
11. Sequential analysis of helminth egg output in human stool samples following albendazole and praziquantel administration.
Scherrer AU; Sjöberg MK; Allangba A; Traoré M; Lohourignon LK; Tschannen AB; N'Goran EK; Utzinger J
Acta Trop; 2009 Mar; 109(3):226-31. PubMed ID: 19070583
[TBL] [Abstract][Full Text] [Related]
12. Host-parasite relationships in infections with two Kenyan isolates of Schistosoma mansoni in NMRI mice.
Thiongo FW; Madsen H; Ouma JH; Andreassen J; Christensen NO
J Parasitol; 1997 Apr; 83(2):330-2. PubMed ID: 9105324
[TBL] [Abstract][Full Text] [Related]
13. Schistosoma mansoni eggs as a target for praziquantel: efficacy of oral application in mice.
Giboda M; Smith JM
J Trop Med Hyg; 1994 Apr; 97(2):98-102. PubMed ID: 8170010
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of mirazid in comparison with praziquantel in Egyptian Schistosoma mansoni-infected school children and households.
Botros S; Sayed H; El-Dusoki H; Sabry H; Rabie I; El-Ghannam M; Hassanein M; El-Wahab YA; Engels D
Am J Trop Med Hyg; 2005 Feb; 72(2):119-23. PubMed ID: 15741544
[TBL] [Abstract][Full Text] [Related]
15. Treatment with praziquantel of schoolchildren with concurrent Schistosoma mansoni and S. haematobium infections in Gezira, Sudan.
Kardaman MW; Fenwick A; el Igail AB; el Tayeb M; Daffalla AA; Dixon HG
J Trop Med Hyg; 1985 Apr; 88(2):105-9. PubMed ID: 3897559
[TBL] [Abstract][Full Text] [Related]
16. Schistosoma mansoni infection in a new settlement in Metekel district, north-western Ethiopia: morbidity and side effects of treatment with praziquantel in relation to intensity of infection.
Fletcher M; Teklehaimanot A
Trans R Soc Trop Med Hyg; 1989; 83(6):793-7. PubMed ID: 2515635
[TBL] [Abstract][Full Text] [Related]
17. Effect of targeted mass treatment on intensity of infection and morbidity in schistosomiasis mansoni: seven-year follow-up of a community in Machakos, Kenya.
DeStigter KV; King CH; Keating CE; Ouma JH; Siongok TK; Mahmoud AA
Trans Assoc Am Physicians; 1989; 102():209-12. PubMed ID: 2517855
[No Abstract] [Full Text] [Related]
18. Assessment of efficacy of praziquantel against Schistosoma mansoni infection.
Massoud AA; el Kholy AM; Anwar WA
J Trop Med Hyg; 1984 Jun; 87(3):119-21. PubMed ID: 6512904
[TBL] [Abstract][Full Text] [Related]
19. Some factors affecting prevalence of and immune responses to Schistosoma mansoni in schoolchildren in Gorgora, northwest Ethiopia.
Degu G; Mengistu G; Jones J
Ethiop Med J; 2002 Oct; 40(4):345-52. PubMed ID: 12596654
[TBL] [Abstract][Full Text] [Related]
20. Field trial on the treatment of fasciolopsiasis with praziquantel.
Bunnag D; Radomyos P; Harinasuta T
Southeast Asian J Trop Med Public Health; 1983 Jun; 14(2):216-9. PubMed ID: 6635761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
